| 摘要: |
| ［摘要］ 目的 探讨诺舒阻抗控制子宫内膜切除系统（NovaSure）治疗月经过多的有效性及安全性。方法 对66例月经过多患者进行NovaSure治疗，术后1、3、6、12个月进行电话随访，观察其疗效及并发症。结果 66例均顺利完成手术，术后1、3、6、12个月有效率分别为98.48%、98.08%、97.06%、100.00%,闭经率分别为43.94%、53.85%、55.88%、62.50%，差异均无统计学意义(P>0.05)。术中、术后无不良反应发生。结论 NovaSure治疗月经过多疗效好而且稳定，安全性好，值得临床推广应用。 |
| 关键词: 诺舒 月经过多 子宫内膜切除 |
| DOI：10.3969/j.issn.1674-3806.2013.12.16 |
| 分类号:R 71 |
| 基金项目: |
|
| NovaSure system in menorrhagia: clinical analysis of 66 cases |
|
WEI Li-ying，ZHAO Ren-feng， LI Xue， et al.
|
|
Department of Obstetrics and Gynecology，the People′s Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021，China
|
| Abstract: |
| ［Abstract］ Objective To investigate the efficiency and safety of NovaSure system for menorrhagia.Methods Sixty-six women with menorrhagia received NovaSure system for treatment. The clinical effect and complications were followed up at months 1, 3, 6 and 12.Results The procedures was completed successfully in all the patients. The rate of efficiency was 98.48%, 98.08%, 97.06%, 100.00% respectively at months 1, 3, 6 and 12. And the rate of amenorrhea was 43.94%, 53.85%, 55.88%, 62.50% respectively. There was no significant difference in the rate of efficiency and amenorrhea among 1, 3, 6 and 12 months(P>0.05). No intraoperative or postoperative complications occurred.Conclusion NovaSure shows high and stable efficiency and safety. It is worthy of clinical application. |
| Key words: NovaSure Menorrhagia Endometrial ablation(EA) |
